Omics underpins novel clues on VDR chemoprevention target in breast cancer

OMICS A Journal of Integrative Biology

Volumn 15, Issue 6, 2011, Pages 337-346

  Muti, Paola ^a   Benassi, Barbara ^a   Falvo, Elisabetta ^a   Santoro, Raffaela ^a   Galanti, Sergio ^a   Citro, Gennaro ^a   Carrubba, Giuseppe ^b   Blandino, Giovanni ^a   Strano, Sabrina ^a,c  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b Experimental Oncology Unit   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; VITAMIN D5;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST TUMOR; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CONCENTRATION RESPONSE; EPITHELIZATION; GENE TECHNOLOGY; GENOME ANALYSIS; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; SKIN CARCINOGENESIS; TUMOR CELL LINE; VITAMIN BLOOD LEVEL; VITAMIN D RESPONSIVE ELEMENT; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 79958712172     PISSN: 15362310     EISSN: 15362310     Source Type: Journal    
DOI: 10.1089/omi.2010.0086     Document Type: Review

References (61)

1. Abbas, S., Linseisen, J., and Chang-Claude, J. (2007). Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case-control study. Nutr Cancer 59, 54-61. (Pubitemid 47549781)
2. Acharya, C.R., Hsu, D.S., Anders, C.K., Anguiano, A., Salter, K.H., Walters, K.S., et al. (2008). Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA 299, 1574-1587. (Pubitemid 351482796)
3. Amit, I., Wides, R., and Yarden, Y. (2007). Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy. Mol Syst Biol 3, 151.
4. Anderson, M.G., Nakane, M., Ruan, X., Kroeger, P.E. and Wu-Wong, J.R. (2006). Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol 57, 234-240. (Pubitemid 41779843)
5. Anzano, M.A., Smith, J.M., Uskokovic, M.R., Peer, C.W., Mullen, L.T., Letterio, J.J., et al. (1994). 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27- hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res 54, 1653-1656.
6. Auman, J.T., and McLeod, H.L. (2010). Now's the time to find biomarkers on purpose. Ann Oncol 21, 193-194.
7. Beres, S. (2008). Vitamin D: cancer prevention's sunny future? J Natl Cancer Inst 100, 292-293, 297.
8. Berger, U., McClelland, R.A., Wilson, P., Greene, G.L., Haussler, M.R., Pike, J.W., et al. (1991). Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1, 25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis. Cancer Res 51, 239-244.
9. Bertone-Johnson, E.R. (2009). Vitamin D and breast cancer. Ann Epidemiol 19, 462-467.
10. Bouillon, R., Carmeliet, G., Verlinden, L., Van Etten, E., Verstuyf, A., Luderer, H.F., et al. (2008). Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29, 726-776.
11. Braga, C., La Vecchia, C., Negri, E., Franceschi, S., and Parpinel, M. (1997). Intake of selected foods and nutrients and breast cancer risk: an age- and menopause-specific analysis. Nutr Cancer 28, 258-263. (Pubitemid 27446653)
12. Bretherton-Watt, D., Given-Wilson, R., Mansi, J.L., Thomas, V., Carter, N., and Colston, K.W. (2001). Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer 85, 171-175. (Pubitemid 32695735)
13. Carlberg, C., Dunlop, T.W., Saramaki, A., Sinkkonen, L., Mati-lainen, M., and Vaisanen, S. (2007). Controlling the chromatin organization of vitamin D target genes by multiple vitamin D receptor binding sites. J Steroid Biochem Mol Biol 103, 338-343. (Pubitemid 46401335)
14. Chen, W.Y., Bertone-Johnson, E.R., Hunter, D.J., Willett, W.C., and Hankinson, S.E. (2005). Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14, 2335-2339. (Pubitemid 41437833)
15. Colston, K.W., Berger, U., Wilson, P., Hadcocks, L., Naeem, I., Earl, H.M., et al. (1988). Mammary gland 1,25-dihydrox-yvitamin D3 receptor content during pregnancy and lactation. Mol Cell Endocrinol 60, 15-22.
16. Cross, H.S., Bareis, P., Hofer, H., Bischof, M.G., Bajna, E., Kri-wanek, S., et al. (2001). 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogen-esis. Steroids 66, 287-292. (Pubitemid 32140906)
17. Deeb, K.K., Trump, D.L., and Johnson, C.S. (2007). Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7, 684-700. (Pubitemid 47327412)
18. Dinh, P., and Sotiriou, C. (2008). Treatment tailoring based on molecular characterizations. Ann Oncol 19(Suppl 7), vii46-50.
19. Dusso, A.S., Brown, A.J., and Slatopolsky, E. (2005). Vitamin D. Am J Physiol Renal Physiol 289, F8-F28. (Pubitemid 40863568)
20. Ein-Dor, L., Zuk, O., and Domany, E. (2006). Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 103, 5923-5928.
21. Esteva, F.J., Yu, D., Hung, M.C., and Hortobagyi, G.N. (2010). Molecular predictors of response to trastuzumab and lapatinib in breast cancer. Nat Rev Clin Oncol 7, 98-107.
22. Freake, H.C., Abeyasekera, G., Iwasaki, J., Marcocci, C., Ma-cIntyre, I., McClelland, R.A., et al. (1984). Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices. Cancer Res 44, 1677-1681. (Pubitemid 14125863)
23. Garland, F.C., Garland, C.F., Gorham, E.D., and Young, J.F. (1990). Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19, 614-622.
24. Garland, C.F., Gorham, E.D., Mohr, S.B., Grant, W.B., Gio-vannucci, E.L., Lipkin, M., et al. (2007). Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 103, 708-711. (Pubitemid 46420519)
25. Garland, C.F., Gorham, E.D., Baggerly, C.A., and Garland, F.C. (2008). Re: prospective study of vitamin D and cancer mortality in the United States. J Natl Cancer Inst 100, 826-827. (Pubitemid 351809664)
26. Geyer, F.C., Marchio, C., and Reis-Filho, J.S. (2009). The role of molecular analysis in breast cancer. Pathology 41, 77-88.
27. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70. (Pubitemid 30046295)
28. Jacobson, E.A., James, K.A., Newmark, H.L., and Carroll, K.K. (1989). Effects of dietary fat, calcium, and vitamin D on growth and mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene in female Sprague-Dawley rats. Cancer Res 49, 6300-6303. (Pubitemid 20000927)
29. Jensen, S.S., Madsen, M.W., Lukas, J., Binderup, L., and Bartek, J. (2001). Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controllingmachinery. Mol Endocrinol 15, 1370-1380. (Pubitemid 32703484)
30. John, E.M., Schwartz, G.G., Dreon, D.M., and Koo, J. (1999). Vitamin D and breast cancer risk: the NHANES I Epidemio-logic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 8, 399-406. (Pubitemid 29230543)
31. Kim, M.S., Fujiki, R., Kitagawa, H., and Kato, S. (2007). 1al-pha,25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 gene. Mol Cell Endocrinol 265-266, 168-173. (Pubitemid 46273961)
32. Kostner, K., Denzer, N., Muller, C.S., Klein, R., Tilgen, W., and Reichrath, J. (2009). The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 29, 3511-3536.
33. Lim, H.S., Roychoudhuri, R., Peto, J., Schwartz, G., Baade, P., and Moller, H. (2006). Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer 119, 1530-1536. (Pubitemid 44258757)
34. Lonning, P.E., Knappskog, S., Staalesen, V., Chrisanthar, R., and Lillehaug, J.R. (2007). Breast cancer prognostication and prediction in the postgenomic era. Ann Oncol 18, 1293-1306. (Pubitemid 47305001)
35. Lowe, L.C., Guy, M., Mansi, J.L., Peckitt, C., Bliss, J., Wilson, R.G., et al. (2005). Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 41, 1164-1169. (Pubitemid 40725575)
36. Masuda, S., and Jones, G. (2006). Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Mol Cancer Ther 5, 797-808. (Pubitemid 43724578)
37. Mathiasen, I.S., Lademann, U., and Jaattela, M. (1999). Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res 59, 4848-4856. (Pubitemid 29472887)
38. Matusiak, D., Murillo, G., Carroll, R.E., Mehta, R.G., and Benya, R.V. (2005). Expression of vitamin D receptor and 25-hydro-xyvitamin D3-1{alpha}- hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev 14, 2370-2376. (Pubitemid 41437839)
39. McCullough, M.L., Rodriguez, C., Diver, W.R., Feigelson, H.S., Stevens, V.L., Thun, M.J., et al. (2005). Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 14, 2898-2904. (Pubitemid 43068822)
40. McIntyre, H., Blue, J., and Harman, J. (2002). A seasonal variation in breast cancer. N Z Med J 115, U45.
41. Mehta, R.G., Moriarty, R.M., Mehta, R.R., Penmasta, R., Laz-zaro, G., Constantinou, A., et al. (1997). Prevention of pre-neoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. J Natl Cancer Inst 89, 212-218. (Pubitemid 27073758)
42. Mohr, S.B. (2009). A brief history of vitamin d and cancer prevention. Ann Epidemiol 19, 79-83.
43. Murayama, A., Kim, M.S., Yanagisawa, J., Takeyama, K., and Kato, S. (2004). Transrepression by a liganded nuclear receptor via a bHLH activator through coregulator switching. EMBO J 23, 1598-1608. (Pubitemid 38579520)
44. Narvaez, C.J., and Welsh, J. (2001). Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem 276, 9101-9107.
45. Ordonez-Moran, P.,and Munoz, A. (2009). Nuclear receptors: genomic and nongenomic effects converge. Cell Cycle 8, 1675-1680.
46. Orlando, F.A., and Brown, K.D. (2009). Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis. Ann Surg Oncol 16, 2270-2279.
47. Palmer, H.G., Sanchez-Carbayo, M., Ordonez-Moran, P., Larriba, M.J., Cordon-Cardo, C., and Munoz, A. (2003). Genetic signa-tures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res 63, 7799-7806. (Pubitemid 37466712)
48. Pendas-Franco, N., Gonzalez-Sancho, J.M., Suarez, Y., Aguilera, O., Steinmeyer, A., Gamallo, C., et al. (2007). Vitamin D regulates the phenotype of human breast cancer cells. Differentiation 75, 193-207. (Pubitemid 46426618)
49. Perou, C.M., Sorlie, T., Eisen, M.B., Van de Rijn, M., Jeffrey, S.S., Rees, C.A., et al. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
50. Porojnicu, A.C., Lagunova, Z., Robsahm, T.E., Berg, J.P., Dahl-back, A., and Moan, J. (2007). Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat 102, 323-328. (Pubitemid 46474836)
51. Sotiriou, C., and Pusztai, L. (2009). Gene-expression signatures in breast cancer. N Engl J Med 360, 790-800.
52. Stadler, Z.K., and Come, S.E. (2009). Review of gene-expression profiling and its clinical use in breast cancer. Crit Rev Oncol Hematol 69, 1-11.
53. Stambolsky, P., Tabach, Y., Fontemaggi, G., Weisz, L., Maor-Aloni, R., Siegfried, Z., et al. (2010). Modulation of the vitamin D3 response by cancer-associated mutant p53. Cancer Cell 17, 273-285.
54. Thorne, J., and Campbell, M.J. (2008). The vitamin D receptor in cancer. Proc Nutr Soc 67, 115-127. (Pubitemid 351543394)
55. Towsend, K., Trevino, V., Falciani, F., Stewart, P.M., Hewison, M., and Campbell, M.J. (2006). Identification of VDR-responsive gene signatures in breast cancer cells. Oncology 71, 111-123.
56. Van de Vijver, M.J., He, Y.D., Van't Veer, L.J., Dai, H., Hart, A.A., Voskuil, D.W., et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347, 1999-2009. (Pubitemid 35461656)
57. Van't Veer, L.J., and Bernards, R. (2008) Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 452 564-570. (Pubitemid 351483370)
58. Welsh, J., Wietzke, J.A., Zinser, G.M., Byrne, B., Smith, K., and Narvaez, C.J. (2003). Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr 133, 2425S-2433S. (Pubitemid 36828849)
59. White, J.H. (2004). Profiling 1,25-dihydroxyvitamin D3-regu-lated gene expression by microarray analysis. J Steroid Bio-chem Mol Biol 89-90, 239-244. (Pubitemid 38844289)
60. Xue, L., Lipkin, M., Newmark, H., and Wang, J. (1999). Influence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in mice. J Natl Cancer Inst 91, 176-181. (Pubitemid 29042696)
61. Yasmin, R., Williams, R.M., Xu, M., and Noy, N. (2005). Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. J Biol Chem 280, 40152-40160. (Pubitemid 41779151)